CRTAM Antikörper (AA 18-286)
Kurzübersicht für CRTAM Antikörper (AA 18-286) (ABIN1983114)
Target
Alle CRTAM Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 18-286
-
Produktmerkmale
- Mouse anti human CRTAM
-
Immunogen
- AA 18-286
-
Isotyp
- IgG2
-
-
anti-Cytotoxic and Regulatory T Cell Molecule (CRTAM) (AA 18-287) antibody
CRTAM Reaktivität: Human FACS, ELISA Wirt: Maus Monoclonal 1C11E10 unconjugated
anti-Cytotoxic and Regulatory T Cell Molecule (CRTAM) (AA 31-130) antibodyCRTAM Reaktivität: Human, Maus FACS, ELISA, IF (cc), IF (p), IHC (fro), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Cytotoxic and Regulatory T Cell Molecule (CRTAM) antibodyCRTAM Reaktivität: Human ELISA, WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cytotoxic and Regulatory T Cell Molecule (CRTAM) (AA 1-393) antibodyCRTAM Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Cytotoxic and Regulatory T Cell Molecule (CRTAM) antibodyCRTAM Reaktivität: Human FACS Wirt: Kaninchen Chimeric unconjugated Fc fragment
anti-Cytotoxic and Regulatory T Cell Molecule (CRTAM) antibodyCRTAM Reaktivität: Maus ELISA (Detection), ELISPOT (Detection) Wirt: Ratte Monoclonal 11-5-CRTAM unconjugated
anti-Cytotoxic and Regulatory T Cell Molecule (CRTAM) antibody (PE)CRTAM Reaktivität: Maus FACS, IP Wirt: Ratte Monoclonal 11-5-CRTAM PE
anti-Cytotoxic and Regulatory T Cell Molecule (CRTAM) antibody (APC)CRTAM Reaktivität: Maus FACS Wirt: Ratte Monoclonal 11-5-CRTAM APC
-
-
Applikationshinweise
- Optimal dilutions should be determined by each laboratory for each application.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- 200 µL of PBS, pH 7.4
-
Konzentration
- 500 µg/mL
-
Buffer
- Lyophilized from a solution containing PBS, pH 7.4
-
Lagerung
- -20 °C
-
-
- CRTAM (Cytotoxic and Regulatory T Cell Molecule (CRTAM))
-
Andere Bezeichnung
- CRTAM
-
UniProt
- O95727
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Activated T Cell Proliferation
Target
-
